1. Hughes D. Pathways to understanding the extended phenotype of parasites in their hosts. J Exp Biol. 2013;216(1):142-7.
2. McConkey GA, Martin HL, Bristow GC, Webster JP. Toxoplasma gondii infection and behaviour–location, location, location? J Exp Biol. 2013;216(1):113-9.
3. Dubey J. Toxoplasmosis of animals and humans: CRC press; 2009.
4. Berdoy M, Webster JP, Macdonald DW. Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci. 2000;267(1452):1591-4.
5. Ihara F, Nishimura M, Muroi Y, Mahmoud ME, Yokoyama N, Nagamune K, et al. Toxoplasma gondii infection in mice impairs long-term fear memory consolidation through dysfunction of the cortex and amygdala. Infect Immun. 2016;84(10):2861-70.
6. Fallahi S, Rostami A, Birjandi M, Zebardast N, Kheirandish F, Spotin A. Parkinson’s disease and Toxoplasma gondii infection: sero-molecular assess the possible link among patients. Acta Trop. 2017;173:97-101.
7. Hsu PC, Groer M, Beckie T. New findings: depression, suicide, and Toxoplasma gondii infection. J Am Assoc Nurse Pract. 2014;26(11):629-37.
8. Bak J, Shim S-H, Kwon Y-J, Lee H-Y, Kim JS, Yoon H, et al. The association between suicide attempts and toxoplasma gondii infection. Clin Psychopharmacol Neurosci. 2018;16(1):95.
9. Cook TB, Brenner LA, Cloninger CR, Langenberg P, Igbide A, Giegling I, et al. “Latent” infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J Psychiatr Res. 2015;60:87-94.
10. Flegr J. Does Toxoplasma infection increase sexual masochism and submissiveness? Yes and no. Commun Integr Biol. 2017;10(5-6):e1303590.
11. Badgaiyan RD. Imaging dopamine neurotransmission in live human brain. Prog Brain Res. 2014;211:165-82.
12. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 2011;6(9):23866.
13. Tedford E, McConkey G. Neurophysiological changes induced by chronic Toxoplasma gondii infection. Pathogens. 2017;6(2):19.
14. Webster JP, Kaushik M, Bristow GC, McConkey GA. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? J Exp Biol. 2013;216(1):99-112.
15. Mahami Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, et al. The correlation between Toxoplasma gondii infection and Parkinson's disease: a case-control study. J Parasit Dis. 2016;40(3):872-6.
16. Ramezani M, Shojaii M, Asadollahi M, Karimialavijeh E, Gharagozli K. Seroprevalence of Toxoplasma gondii in Iranian patients with idiopathic Parkinson's disease. Clin Exp Neuroimmunol. 2016;7(4):361-5.
17. Ho YC, Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection. J Microbiol Immunol Infect. 2008;41(5):386-92.
18. Sommer A, Winner B, Prots I. The Trojan horse-neuroinflammatory impact of T cells in neurodegenerative diseases. Mol Neurodegener. 2017;12(1):1-10.
19. D'Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factorα signaling during peripheral organ inflammation. J Neurosci. 2009;29(7):2089-102.
20. Chao Y, Wong SC, Tan EK. Evidence of inflammatory system involvement in Parkinson's disease. Biomed Res Int. 2014;2014:308654.
21. Chung IY, Benveniste E. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol. 1990;144(8):2999-3007.
22. Schöbitz B, Voorhuis DAM, De Kloet ER. Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci Lett. 1992;136(2):189-92.
23. Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, et al. Inflammatory response in Parkinson's disease (Review). Mol Med Rep. 2014;10(5):2223-33.
24. Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, et al. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012;32(34):11706-15.
25. Sawada M, Imamura K, Nagatsu T, editors. Role of cytokines in inflammatory process in Parkinson’s disease 2006; Vienna: Springer Vienna.
26. Bardou I, Kaercher RM, Brothers HM, Hopp SC, Royer S, Wenk GL. Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem. Neurobiol Aging. 2014;35(5):1065-73.
27. Suzuki Y. Host resistance in the brain against Toxoplasma gondii. J Infect Dis. 2002;185(1):58-65.
28. Kotsimbos A, Hamid Q. IL-5 and IL-5 receptor in asthma. Mem Inst Oswaldo Cruz. 1997;92:75-91.

29. Nickdel MB, Roberts F, Brombacher F, Alexander J, Roberts CW. Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection. Infect Immun. 2001;69(2):1044-52.
30. Zhang Y, Denkers EY. Protective role for interleukin-5 during chronic Toxoplasma gondii infection. Infect Immun. 1999;67(9):4383-92.

31.          Delibas S, Turgay N, GÜRÜZ A. The role of cytokines in the immunopathogenesis of toxoplasmosis. Turkiye Klinikleri J . 2009;29(5).